NASDAQ: AVXL
Anavex Life Sciences Corp Stock Ownership - Who owns Anavex Life Sciences?

Insider buying vs selling

Have Anavex Life Sciences Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher U. MisslingPresident and CEO2025-09-11187,500$5.04
$945.00kBuy
Christopher U. MisslingPresident and CEO2025-09-11145,048$9.58
$1.39MSell

1 of 1

AVXL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVXL insiders and whales buy or sell their stock.

AVXL Shareholders

What type of owners hold Anavex Life Sciences Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc8.21%7,609,618$18.95MInstitution
State Street Corp4.87%4,512,028$11.23MInstitution
Vanguard Capital Management LLC4.17%3,863,950$9.62MInstitution
Two Sigma Investments LP3.50%3,247,888$8.09MInstitution
Geode Capital Management LLC2.36%2,188,275$5.45MInstitution
Christopher U. Missling1.63%1,510,165$3.76MInsider
Athanasios Skarpelos1.41%1,306,458$3.25MInsider
Susquehanna International Group LLP1.07%995,663$2.48MInstitution
Summit Financial LLC1.01%940,455$2.34MInstitution
George Kalkanis0.97%900,000$2.24MInsider

1 of 3

AVXL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVXL43.15%4.79%Net Buying
FULC62.71%37.29%Net SellingNet Buying
TTRX1.55%58.04%Net Buying
CAPR46.48%53.52%Net BuyingNet Buying
ARTV47.68%52.32%Net BuyingNet Buying

Anavex Life Sciences Stock Ownership FAQ

Who owns Anavex Life Sciences?

Anavex Life Sciences (NASDAQ: AVXL) is owned by 43.15% institutional shareholders, 4.79% Anavex Life Sciences insiders, and 52.06% retail investors. Christopher U. Missling is the largest individual Anavex Life Sciences shareholder, owning 1.51M shares representing 1.63% of the company. Christopher U. Missling's Anavex Life Sciences shares are currently valued at $4.08M.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.